Demidenko Zoya N, Korotchkina Lioubov G, Gudkov Andrei V, Blagosklonny Mikhail V
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9660-4. doi: 10.1073/pnas.1002298107. Epub 2010 May 10.
The tumor suppressor p53 is a canonical inducer of cellular senescence (irreversible loss of proliferative potential and senescent morphology). p53 can also cause reversible arrest without senescent morphology, which has usually been interpreted as failure of p53 to induce senescence. Here we demonstrate that p53-induced quiescence actually results from suppression of senescence by p53. In previous studies, suppression of senescence by p53 was masked by p53-induced cell cycle arrest. Here, we separated these two activities by inducing senescence through overexpression of p21 and then testing the effect of p53 on senescence. We found that in p21-arrested cells, p53 converted senescence into quiescence. Suppression of senescence by p53 required its transactivation function. Like rapamycin, which is known to suppress senescence, p53 inhibited the mTOR pathway. We suggest that, while inducing cell cycle arrest, p53 may simultaneously suppress the senescence program, thus causing quiescence and that suppression of senescence and induction of cell cycle arrest are distinct functions of p53. Thus, in spite of its ability to induce cell cycle arrest, p53 can act as a suppressor of cellular senescence.
肿瘤抑制因子p53是细胞衰老(增殖潜能的不可逆丧失和衰老形态)的典型诱导因子。p53也可导致无衰老形态的可逆性停滞,这通常被解释为p53无法诱导衰老。在此我们证明,p53诱导的静止实际上是由p53对衰老的抑制所致。在以往研究中,p53对衰老的抑制被p53诱导的细胞周期停滞所掩盖。在此,我们通过过表达p21诱导衰老,然后检测p53对衰老的影响,将这两种活性区分开来。我们发现,在p21停滞的细胞中,p53将衰老转化为静止。p53对衰老的抑制需要其反式激活功能。与已知可抑制衰老的雷帕霉素一样,p53抑制mTOR通路。我们认为,在诱导细胞周期停滞的同时,p53可能会同时抑制衰老程序,从而导致静止,并且衰老抑制和细胞周期停滞诱导是p53的不同功能。因此,尽管p53有诱导细胞周期停滞的能力,但它可作为细胞衰老的抑制因子发挥作用。